ANROVSCTSO• 28 Days (Normalized)
ANRO vs CTSO (Alto Neuroscience Inc. vs Cytosorbents Corporation)
Showing Closing Date Range from Sep 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
-21.88%
Alto Neuroscience Inc.
Normalized Baseline0.00%
CTSO Performance $4.91
+1352.66%
Cytosorbents Corporation
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
-1374.54 pts
CTSO outperforming by 1374.54 percentage points
ANROCTSO
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO CTSO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(16 dates)
| Date | ANRO Price | ANRO Gain (%) | CTSO Price | CTSO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $27.50 | -21.88% | $4.91 | +1352.66% | -1374.54% |
| Sep 22, 2026 | $30.78 | -12.56% | $- | - | |
| Sep 21, 2026 | $30.63 | -12.98% | $5.51 | +1530.18% | -1543.16% |
| Sep 18, 2026 | $30.27 | -14.01% | $5.75 | +1601.18% | -1615.19% |
| Sep 17, 2026 | $30.98 | -11.99% | $5.76 | +1604.14% | -1616.13% |
| Sep 16, 2026 | $30.00 | -14.77% | $5.73 | +1595.27% | -1610.04% |
| Sep 15, 2026 | $30.25 | -14.06% | $6.06 | +1692.90% | -1706.96% |
| Sep 14, 2026 | $31.68 | -10.00% | $6.07 | +1695.86% | -1705.86% |
| Sep 11, 2026 | $32.00 | -9.09% | $6.41 | +1796.45% | -1805.54% |
| Sep 10, 2026 | $31.68 | -10.00% | $6.37 | +1784.62% | -1794.62% |
| Sep 09, 2026 | $34.07 | -3.21% | $6.33 | +1772.78% | -1775.99% |
| Sep 08, 2026 | $35.81 | +1.73% | $- | - | |
| Sep 04, 2026 | $35.55 | +0.99% | $0.35 | +3.55% | -2.56% |
| Sep 03, 2026 | $36.40 | +3.41% | $0.35 | +3.55% | -0.14% |
| Sep 02, 2026 | $36.64 | +4.09% | $0.38 | +13.61% | -9.52% |
Page 1 of 2